(Q50222434)

27 February 2018

title

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. (English)

1 reference

27 February 2018

3

Gaston De Serres

1 reference

27 February 2018

Geneviève Deceuninck

series ordinal

2

object named as

Geneviève Deceuninck

1 reference

27 February 2018

Philippe De Wals

series ordinal

1

object named as

Philippe De Wals

1 reference

27 February 2018

language of work or name

English

0 references

publication date

1 April 2016

1 reference

27 February 2018

published in

Vaccine

1 reference

27 February 2018

volume

34

1 reference

27 February 2018

issue

18

1 reference

27 February 2018

page(s)

2053-2054

1 reference

27 February 2018

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.104

Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.104

Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.104

Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.104

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.104

10.1016/J.VACCINE.2015.06.104

7 January 2021

Identifiers

DOI

1 reference

27 February 2018

1 reference

27 February 2018